JTJiyu Tong

Jiyu Tong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiyu Tong has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Dezhi Mu

    Department of Pediatrics, West China Second University Hospital, Sichuan University, China

    1 shared publication
  • Dong Deng

    Laboratory of Epigenetics and Immunology, West China Institute of Women and Children’s Health, NHC Key Laboratory of Chronobiology, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Guangchao Cao

    The Biomedical Translational Research Institute, Health Science Center (School of Medicine), Jinan University, Guangzhou, China

    1 shared publication
  • Juxiu Liu

    Laboratory of Epigenetics and Immunology, West China Institute of Women and Children’s Health, NHC Key Laboratory of Chronobiology, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Kepan Linghu

    Laboratory of Epigenetics and Immunology, West China Institute of Women and Children’s Health, NHC Key Laboratory of Chronobiology, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Keren Peng

    Laboratory of Epigenetics and Immunology, West China Institute of Women and Children’s Health, NHC Key Laboratory of Chronobiology, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China

    1 shared publication

Latest Publications

  • DDX55 safeguards naïve T cell homeostasis by suppressing activation-promoting transposable elements

    by Mengyue Wu, Kepan Linghu, Qimin Yin, Ping He, Xinyang Yu, Peng Hu, Rongying He, Qinyun Du, Shengli Wang, Xi Chen, et al.

    Naïve T cells are maintained in a homeostatic state to preserve a stable T cell pool with diverse T cell receptor (TCR) repertoires, ensuring preparedness for priming. However, the underlying mechanisms controlling naïve T cell homeostasis and priming remain unclear. Leveraging a machine learning–based functional genetic screen, we identified DEAD-box helicase 55 ( Ddx55 ) as the top factor responsible for naïve T cell homeostasis. DDX55 was highly expressed in naïve T cells and suppressed enhancer- and promoter-like transposable elements (TEs) near T cell activation–associated genes. Ddx55 loss led to derepression of these TEs, resulting in TE-derived R loops and genomic instability, ultimately disrupting naïve T cell homeostasis and abolishing T cell proliferation. Mechanistically, DDX55-targeted TEs harbored myelocytomatosis oncogene (MYC)–binding motifs. DDX55 directly bound MYC and restricted its access to these TE loci, thereby preventing inappropriate TE activation in naïve T cells. Thus, naïve T cells exploit DDX55 as a vital regulator of T cell activation, ensuring their genomic stability and homeostatic maintenance.